Alpha Cognition (ACOG) Current Deferred Revenue (2023 - 2025)

Alpha Cognition's (ACOG) quarterly Current Deferred Revenue came in at $153171.0 in Q4 2025, up 92.32% year-on-year from $79643.0 in Q4 2024, and down 49.15% quarter-over-quarter from $301216.0 in Q3 2025.

Alpha Cognition (ACOG) Current Deferred Revenue (2023 - 2025) Analysis & Trends

Alpha Cognition's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $153171.0 for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 92.32% year-over-year to $153171.0 in Q4 2025; TTM through Dec 2025 was $153171.0, a 92.32% increase from a year earlier, with the FY2025 full-year figure at $153171.0, up 92.32% from the prior year.
  • Current Deferred Revenue declined to $153171.0 in Q4 2025 per ACOG's latest filing, from $301216.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $301216.0 in Q3 2025 and bottomed at $10413.0 in Q4 2023.
  • The 3-year median for Current Deferred Revenue is $116407.0 (2024), against an average of $136936.2.
  • Biggest YoY gain for Current Deferred Revenue was 702.26% in 2025; the steepest drop was 92.32% in 2025.
  • Year by year, Current Deferred Revenue stood at $10413.0 in 2023, then surged by 664.84% to $79643.0 in 2024, then jumped by 92.32% to $153171.0 in 2025.
  • Per Business Quant, the three latest ACOG Current Deferred Revenue figures stand at $153171.0 (Q4 2025), $301216.0 (Q3 2025), and $231836.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alpha Cognition 145.51 Mn 79.41 Mn 2.61 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 153,171.00
Sep 30, 2025 301,216.00
Jun 30, 2025 231,836.00
Mar 31, 2025 239,536.00
Dec 31, 2024 79,643.00
Sep 30, 2024 50,777.00
Jun 30, 2024 28,898.00
Dec 31, 2023 10,413.00